Uganda has officially joined the Global Access to Oncology Medicines (ATOM) Coalition, a move expected to significantly improve the availability and affordability of cancer drugs.
For many families in Uganda, a cancer diagnosis has historically felt like a “sentence of despair”—not just because of the biological toll of the disease, but because of the staggering financial wall that stands between a patient and life-saving treatment. However, on Monday, March 30, 2026, Uganda officially turned a corner in its fight against the disease by joining the Global Access to Oncology Medicines (ATOM) Coalition.
This milestone, launched at a high-level event in Kampala, represents a systemic shift in how Uganda will procure, distribute, and administer cancer drugs. By joining this UICC-led initiative, the country is moving toward a future where the availability of medicine is dictated by medical need rather than a patient’s bank balance.
What is the ATOM Coalition?
The ATOM Coalition is a global partnership that brings together over 40 organizations from the private sector, civil society, and the public sector. Its primary mission is simple but revolutionary: to reduce cancer-related suffering in low- and lower-middle-income countries (LLMICs) by removing the barriers to availability, affordability, and appropriate use of oncology medicines.
In Uganda, where the Uganda Cancer Institute (UCI) estimates over 35,000 new cancer casesannually, the coalition’s arrival provides the “muscle” needed to fix a fractured supply chain.
The Three Pillars of the ATOM Strategy in Uganda:
- Lowering Costs through Pooled Purchasing: Instead of Uganda negotiating prices for essential medicines alone, the ATOM Coalition uses “pooled purchasing” and efficient negotiation mechanisms with generic and biosimilar manufacturers. This creates economies of scale that can slash the price of diagnostics and drugs.
- Expanding Access to Patented Drugs: Through voluntary licensing and indirect commercialization, the coalition helps bring new, high-tech patented medicines into the country—drugs that were previously far too expensive for the national budget.
- Strengthening Health Systems: The coalition doesn’t just “drop off” medicine. It invests in training Ugandan doctors, nurses, and laboratory staff on how to use these medicines safely and effectively.
Why This Matters: The Statistics of Survival
To understand the weight of this milestone, one must look at the current reality of cancer care in Sub-Saharan Africa. Currently, it is estimated that less than 50% of the cancer medicines on the WHO Model List of Essential Medicines are available in countries like Uganda.
The Financial Toxicity
A 2022 study highlighted a grim reality: almost all cancer treatment regimens in Uganda were unaffordable for patients paying out-of-pocket. For many households, a single course of chemotherapy could consume more than 40% of their total annual expenses, leading to “catastrophic expenditure” and, tragically, treatment abandonment.
By joining ATOM, the Ugandan government and the African Palliative Care Association (APCA) are signaling that “geography should not be destiny.” If a child in Kampala has a treatable leukemia, their survival should not depend on whether they live in a high-income country.
Kampala as a “City Cancer Challenge” Hub
The ATOM Coalition launch follows closely on the heels of Kampala officially joining the City Cancer Challenge (C/Can) network just last week. This “double-win” creates a powerful synergy:
- C/Can focuses on improving the infrastructure of cancer care in the city (better diagnostics, better data systems, and better referral paths).
- ATOM provides the fuel for that infrastructure by ensuring the pharmacies and labs are actually stocked with the necessary drugs and reagents.
Dr. Jackson Orem, Executive Director of the Uganda Cancer Institute, emphasized that this is a “group fight.” The UCI is already a regional center of excellence for East Africa; these global partnerships will now allow it to fulfill that role with more modern tools.
The Road Ahead: Precision Medicine and Training
One of the most exciting aspects of the ATOM Coalition is its focus on precision diagnostics. Already, the coalition has made mRNA precision diagnostics for Chronic Myeloid Leukaemia (CML) available in LLMICs. For Uganda, this means doctors can move away from “one-size-fits-all” chemotherapy toward targeted therapies that have fewer side effects and higher success rates.
The Implementation Phase
The “pre-implementation” phase involves a deep dive into Uganda’s specific needs—a situational analysis to see where the bottlenecks are. Is it the regulatory process at the National Drug Authority (NDA)? Is it the cold-chain storage at National Medical Stores (NMS)?
Once these gaps are identified, the coalition will deploy a three-year action plan (similar to the one recently launched in Zambia) to fix them permanently.
A Collective Promise
At the launch at the Sheraton Hotel in Kampala, leaders from the Ministry of Health, the World Health Organization, and various cancer research centers signed a formal pledge to ensure these medicines reach the people who need them safely.
As the African Palliative Care Association noted, cancer is often viewed as a “death sentence” in Africa due to poor five-year survival rates. With the ATOM Coalition, Uganda is rewriting that narrative. The goal is no longer just “palliative care” (making the end of life comfortable), but curative care(giving patients a genuine chance to beat the disease).
Conclusion
Uganda’s entry into the ATOM Coalition is a bold statement of health equity. It acknowledges that while science has made incredible breakthroughs in oncology, those breakthroughs are meaningless if they don’t reach the bedside of a patient in Mulago or Gulu. Today, the “medicine gap” in Uganda has begun to close.
